Valuation check: PXYN's profit margin is 13.09%, below the Healthcare sector average of 21.34%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2019
Trailing 12 months ending Sep 2019
Praxsyn (PXYN) currently reports a profit margin of 13.09% as of September 2019. That compares with 6.66% in the prior-year period — up 96.5% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Praxsyn's profit margin history and peer comparisons.
Praxsyn's profit margin increased from 6.66% to 13.09% — a 96.5% year-over-year increase (period ending September 2019). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Praxsyn's profit margin of 13.09% is lower than the Healthcare sector average of 21.34%. That is roughly 38.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Praxsyn's current 13.09% should be judged against Healthcare norms (sector average: 21.34%) and against PXYN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 13.09%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Praxsyn, and consider following PXYN for alerts when major investors trade the stock.